Augmenting Language Therapy for Aphasia: Levodopa

NCT01429077 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Nonfluent Aphasia
Stroke

Interventions

DRUG: levodopa/carbidopa
DRUG: Placebo comparator

Sponsor

Shirley Ryan AbilityLab

Collaborators

[object Object]